Although systematic studies concerning the latency between the start of treatment and the phenotype switch in EGFR-mutant adenocarcinoma are lacking, in the large series of cases studied by Ferrer [119] and Marcoux [111] the median time to transformation was 16 months and 17.8 months, respectively. Here, EGFR is linked to adenocarcinoma.